|
|
Volumn 6, Issue 5, 1999, Pages 436-458
|
|
Angiogenesis and cancer control: From concept to therapeutic trial
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANGIOGENESIS INHIBITOR;
CAPTOPRIL;
CGS 27023A;
CM 101;
COMBRETASTATIN;
COPPER;
ENDOSTATIN;
FUMAGILLOL CHLOROACETYLCARBAMATE;
INTERLEUKIN 12;
MARIMASTAT;
PENICILLAMINE;
PRINOMASTAT;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
PROTEINASE INHIBITOR;
SURAMIN;
TETRATHIOMOLYBDIC ACID;
THALIDOMIDE;
ANGIOGENESIS;
ARTICLE;
CANCER;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
HUMAN;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
SIGNAL TRANSDUCTION;
|
|
EID: 0032756159
PISSN: 10732748
EISSN: None
Source Type: Journal
DOI: 10.1177/107327489900600502 Document Type: Article |
|
Times cited : (134)
|
|
References (185)
|
